Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2003
12/04/2003US20030225093 Cyclic gmp-specific phosphodiesterase inhibitors
12/04/2003US20030225092 E.g., 6-Benzo(1,3)dioxol-5-yl-10-hydroxy-2-methyl-2,3,6,7,12, 12a-hexa-hydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione potent and selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225072 Opioid receptor active compounds
12/04/2003US20030225065 Use of 4-(1,4-diazepan-1-yl)- or 4-piperazin-1-yl-2-aminophenyl phenyl sulfones for treatment of disorders of the central nervous system.
12/04/2003US20030225060 Acylated piperidine derivatives as melanocortin-4 receptor agonists
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030225056 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/04/2003US20030225051 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
12/04/2003US20030225050 Process for production of crystals of 11ss-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
12/04/2003US20030225048 Sulfatase inhibiting continuous progestogen contraceptive regimens
12/04/2003US20030225047 Sulfatase inhibiting progestogen-only contraceptive regimens
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224073 Cinnamomi and poria composition, method to prepare same and uses thereof
12/04/2003US20030223958 Use of interleukin-19 to treat ovarian cancer
12/04/2003US20030223956 Macromers having a backbone comprising a polymeric backbone comprising units with a 1,2- diol or 1,3-diol structure, such as polyvinyl alcohol, and pendant chains bearing crosslinkable groups and other modifiers. When crosslinked, the macromers
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2487419A1 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
12/04/2003CA2487279A1 Progestagenic dosage units
12/04/2003CA2487268A1 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
12/04/2003CA2487167A1 Combination of a dpp iv inhibitor and a cardiovascular compound
12/04/2003CA2486966A1 Substituted quinazolinone compounds
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2484288A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2480742A1 Tropane compounds
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1366049A2 Pirazino[1'2':1,6]pyrido[3,4-b]indole derivatives
12/03/2003EP1366030A2 Melanin concentrating hormone receptor ligands
12/03/2003EP1366028A1 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors
12/03/2003EP1366025A1 Agonists of beta-adrenoceptors
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366007A2 Compounds with high monoamine transporter affinity
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365794A2 Prevention and treatment of sexual arousal disorders
12/03/2003EP1365768A2 Use of erss-selective ligands for regulating fertility and compounds useful therefore
12/03/2003EP1365766A2 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
12/03/2003EP1365765A2 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
12/03/2003EP1365760A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/03/2003EP1365740A1 Rapid-onset medicament for the treatment of sexual dysfunction
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1150963B1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
12/03/2003EP0854705B1 Hormone dispenser for hormone replacement therapy method
12/03/2003CN1460105A 黄嘌呤磷酸二酯酶v抑制剂 Xanthine phosphodiesterase inhibitor v
12/03/2003CN1459314A Composition for preventing and treating milk cow from bateria disease
12/03/2003CN1459309A Plaster for treating proliferation of mammary gland
12/03/2003CN1459306A Pure traditional Chinese medicine prepn. for treating male sterility, and its prepn. method
12/03/2003CN1459284A Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/03/2003CN1129582C 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129444C Antiabortifacient for treating acyesis and sterility and its preparing process
12/03/2003CN1129443C Medicine for treating impotence
12/03/2003CN1129441C Medicine for curing metritis
12/03/2003CN1129428C Endothelin receptor antagonists
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656936 Growth inhibitors of Candida albicans, and anti-HIV agents
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2224284C Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients
12/02/2003CA2132865C Transdermal administration of oxybutynin
11/2003
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097636A1 Novel compounds and their use
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097164A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097069A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003WO2003097063A1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
11/27/2003WO2003097058A1 New pharmaceutical compositions containing flibanserin polymorph a
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003096980A2 Bicyclic modulators of androgen receptor function
11/27/2003WO2003066594A3 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/27/2003WO2003055505A3 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003051383A3 Use of hmgb proteins and nucleic acids that code therefor
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006620A3 Linear and cyclic melanocortin receptor-specific peptides
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2000050046A8 Stabilized oral pharmaceutical composition containing iodide and iodate and method
11/27/2003US20030221206 Using in vitro fertilization to produce gentically engineered animals for use as models for prevention and treatment of disease
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 557